Tehran University of Medical Sciences
home | Farsi
Print

Azita Hajhossein Talasaz

Contact Information
Tel: 66954709
Fax: 66954709
Address: Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences
Academic Rank
Associate Professor
School
Medicine
Pharmacotherapy
About
CV last edited on: 2016/18/06

1.

Resident


Residency training program in Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran, 2007-2011
2.

Pharm D


Tehran University of Medical Sciences, Tehran, Iran, 2001-2006
1.

English


2.

Persian


Speaking: Native, Reading: Native, Writing: Native
1.

Board Certified Pharmacotherapy Specialist (BCPS)


2012,
2.

First Place Position in Board of Pharmacotherapy , Shahid Beheshti University of Medical Sciences, Tehran, Iran


2011,

Scientific Position

1.

Assistant Professor


Department of Clinical Pharmacy, Tehran University of Medical Sciences, 2011

Farsi

1.

Pharmacotherapy of Renal Disorders


Authors: Dashti-Khavidaki S, Talasaz AH, Khalili H
Persian, Publisher: Arjmand Publisher, 2011, Original
2.

Pharmacotherapy of Gastrointestinal Disorders


Authors: Khalili H, Talasaz AH
Persian, Publisher: Arjmand Publisher, 2011, Original

Papers

English

1.

Changes in gram negative microorganisms’ resistance pattern during 4 years period in a referral teaching hospital; a surveillance study


Authors: . Khalili H, Dashti-Khavidaki S, Shahidi MR, Abdollahi A, Jafari S, Jahangard-Rafsanjani Z, Talasaz AH.
Daru Journal of Pharmaceutical Science, Vol.20, No.28, Year. 2012,
2.

Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center.


Authors: Khalili H, Talasaz AH, Jenab Y, Salarifar M.
J Cardiovasc Med (Hagerstown), Vol.13, No.11, Year. 2012, Page:708-15,
3.

Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation


Authors: Ahmad MZ, Akhter S, Anwar M, Kumar A, Rahman M, Talasaz AH, Ahmad FJ.
Drug Dev Ind Pharm, Year. 2012,
4.

The potential role of clinical pharmacy services in patients with cardiovascular diseases.


Authors: Talasaz AH
J Tehran Heart Cent, Vol.7, No.2, Year. 2012, Page:41-6,
5.

A Drug Utilization Evaluation Study of Amphotericin B in Neutropenic Patients in a Teaching Hospital in Iran


Authors: Tavakoli-Ardakani M, Eshraghi A, Talasaz AH, Salamzadeh J
Iranian Journal of Pharmaceutical Research, Vol.11, No.1, Year. 2012, Page:151-156,
6.

Adherence to Antiretroviral Therapy Among Iranian HIV/AIDS Patients


Authors: Khalili H, Rohani R, Seyedalinaghi S, Hajiabdolbaghi M, Dashti-Khavidaki S, Talasaz AH
Current Clinical Pharmacology, Year. 2012,
7.

Evaluation of the pattern of human albumin utilization at a university affiiated hospital


Authors: Talasaz AH, Jahangard-Rafsanjani Z, Ziaie S, Fahimi F
Archives of Iranian Medicine, Vol.15, No.2, Year. 2012, Page:85-87,
8.

Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction


Authors: Khalili H, Talasaz AH, Salarifar M
Clinical Research in Cardiology, Year. 2011,
9.

Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis


Authors: Dashti-Khavidaki S, Chamani N, Khalili H, Talasaz AH, Ahmadi F, Lessan-Pezeshki M, Ghaeli P, Dalili S, Alimadadi A
Iranian Journal of Kidney Disease, Vol.5, No.6, Year. 2011, Page:404-409,
10.

The Bioavailability of Salbutamol in Urine via Volumatic and Nonvolumatic Valved Holding Chambers


Authors: Fahimi F, Kobarfard F, Salamzadeh J, Fakharian A, Abdolahi P, Talasaz AH, Mahboobi Pour H, Baniasadi S, Masjedi M
World Allergy Organization Journal, Vol.4, No.11, Year. 2011, Page: 179-183,
11.

Plasma Vitamin C concentrations in patients on routine hemodialysis and its relationship to patients' morbidity and mortality


Authors: Dashti-Khavidaki S, Talasaz AH, Tabeefar H, Hajimahmoodi M, Moghaddam G, Khalili H, Lessan-Pezeshki M, Jahanmardi A
International Journal for Vitamin and Nutrition Research, Vol.81, No.4, Year. 2011, Page:197-203,
12.

The Evaluation of Albumin Utilization in a Teaching University Hospital in Iran


Authors: Jahangard-Rafsanjan Z, Javadi MR, Torkamandi H, Alahyari S, Talasaz AH, Gholami K
Iranian Journal of Pharmaceutical Research, Vol.10, No.2, Year. 2011, Page:385-390,
13.

Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine


Authors: Khalili H, Soudbakhsh A, Talasaz AH
American Journal of Health System Pharmacy, Vol.68, No.10, Year. 2011, Page:888-892,
14.

Potential role of N-acetylcysteine in cardiovascular disorders


Authors: Talasaz AH, Khalili H, Fahimi F, Salarifar M
Therapy, Vol.8, No.3, Year. 2011, Page:237-245,
15.

Anticoagulant utilization evaluation in a teaching hospital: a prospective study


Authors: Khalili H, Dashti-Khavidaki S, Talasaz AH, Najmedin F, Hosseinpoor R
Journal of Pharmacy Practice, Vol.23, No.6, Year. 2010, Page:579-584,
16.

Tribulus terrestris-induced severe nephrotoxicity in a young healthy male


Authors: Talasaz AH, Abbasi MR, Abkhiz S, Dashti-Khavidaki S
Nephrology Dialysis Transplantation, Vol.25, No.11, Year. 2010, Page:3792-3793,
17.

Is deep vein thrombosis prophylaxis appropriate in the medical wards? A clinical pharmacists' intervention study


Authors: Khalili H, Dashti-Khavidaki S, Talasaz AH, Mahmoudi L, Eslami K, Tabeefar H
Pharmacy World and Science, Vol.32, No.5, Year. 2010, Page:594-600,
18.

Approach to Pandemic 2009 influenza: first report from a main referral hospital for Pandemic H1N1 influenza care in Iran


Authors: Dashti-Khavidaki S, Khalili H, Gholamalipour F, Soudbakhsh A, Talasaz AH, Hajabdolbaghi M, Rasoolinejad M, Mokhtari Azad T, Fathi M, Talebian MT, Nasiripour S
Journal of Infection in Developing Countries, Vol.4, No.10, Year. 2010, Page:629-635,
19.

Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward


Authors: Khalili H, Dashti-Khavidaki S, Talasaz AH, Tabeefar H, Hendoiee N
Journal of Managed Care Pharmacy, Vol.16, No.2, Year. 2010, Page:114-121,
20.

In situ gel forming systems of poloxamer 407 and hydroxypropyl cellulose or hydroxypropyl methyl cellulose mixtures for controlled delivery of vancomycin


Authors: Talasaz AH, Ghahremankhani AA, Moghadam SH, Malekshahi MR, Atyabi F, Dinarvand R
Journal of Applied Polymer Science, Vol.109, No.4, Year. 2008, Page:2369-2374,

Farsi

1.

Drug induced hypomagnesemia


Authors: Dashti-Khavidaki S, Talasaz AH, Eshraghi A
Razi, Vol.11, No.263, Year. 1390, Page:18-22,
2.

Drug induced hypophosphatemia


Authors: Dashti-Khavidaki S, Eshraghi A, Talasaz AH
Razi, Vol.9, No.261, Year. 1390, Page:30-35,
3.

Drug induced hyperkalemia


Authors: Dashti-Khavidaki S, Talasaz AH, Eshraghi A
Razi, Vol.7, No.259, Year. 1390, Page:12-16,
4.

Drug induced hypernatremia


Authors: Dashti-Khavidaki S, Eshraghi A, Talasaz AH
Razi, Vol.6, No.258, Year. 1390, Page: 25-28,
5.

Antimicrobials induced hepatotoxicity


Authors: Eshraghi A, Talasaz AH
Razi, Vol.4, No.256, Year. 1390, Page:32-35,
1.

American College of Clinical Pharmacy


Activity Type:Member
2011
2.

Iranian Society of Clinical Pharmacy (ISCP)


Activity Type:Member
2009-present
3.

The National Ellite Foundation


Activity Type:Member
2007-present
4.

Medical Council of the Islamic Republic of Iran


Activity Type:Member
2006-present
5.

Iranian Pharmaceutical Association


Activity Type:Member
2003-present
Top